Showing posts with label Oral Solution. Show all posts
Showing posts with label Oral Solution. Show all posts
Tuesday, January 27, 2026

FDA Approves Javadin (clonidine hydrochloride) Oral Solution for the Treatment of Hypertension

›
In continuation of my update on Clonidine Azurity Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) approval of  J...
Saturday, December 13, 2025

FDA Approves Vostally (ramipril) Oral Solution for the Treatment of Hypertension in Adults

›
Rosemont Pharmaceuticals, Inc. announced  the U.S. Food and Drug Administration (FDA)  approval of  Vostally (ramipril) Oral Solution, an an...
Wednesday, November 19, 2025

FDA Approves Khindivi (hydrocortisone) Oral Solution for Pediatric Patients with Adrenocortical Insufficiency

›
Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercia...
Wednesday, August 13, 2025

FDA Approves Arynta (lisdexamfetamine) Oral Solution for ADHD and Binge Eating Disorder

›
In continuation of my update on  lisdexamfetamine Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals' Arynta™ (lisd...
Tuesday, October 1, 2024

FDA Approves Xromi (hydroxyurea) Oral Solution for Use in Pediatric Patients with Sickle Cell Anemia

›
The U.S. Food and Drug Administration (FDA) has approved Xromi, an oral solution formulation of hydroxyurea indicated to reduce the frequenc...
Wednesday, March 2, 2022

FDA Approves Norliqva (amlodipine) Oral Solution for Hypertension and Coronary Artery Disease

›
In continuation of my update on  amlodipine besylate The U.S. Food and Drug Administration has approved Norliqva (amlodipine) oral solution ...